| Stacy Brown, OT | |
|
901 18th St E, Tifton, GA 31794-3648 | |
| (229) 353-6124 | |
| (229) 353-7722 |
| Full Name | Stacy Brown |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Occupational Health |
| Location | 901 18th St E, Tifton, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952723603 | NPI | - | NPPES |
| OTA001175 | Other | GA | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SX0106X | Clinical Nurse Specialist - Occupational Health | OTA001175 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stacy Brown, OT 901 18th St E, Tifton, GA 31794-3648 Ph: (229) 353-6124 | Stacy Brown, OT 901 18th St E, Tifton, GA 31794-3648 Ph: (229) 353-6124 |
News Archive
A microfluidic device developed at Massachusetts General Hospital may help study key steps in the process by which cancer cells break off from a primary tumor to invade other tissues and form metastases.
Using new technology associated with the study of proteins, or proteomics, scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and their colleagues have made a step toward predicting which people with familial adenomatous polyposis (FAP), an inherited condition that often leads to colon cancer, will respond to the prevention drug celecoxib.
The number of Americans buying prescription drugs to treat digestive conditions climbed over 50 percent, rising from 18.1 million to 29 million people between 1997 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
The Washington Post: "The agreement for Baltimore-based Johns Hopkins Health System to acquire Sibley Memorial Hospital is likely to be approved by District officials as soon as Thursday, giving the world-class academic medical center its first foothold in the District. Driven by Sibley's need to ensure long-term financial stability by increasing its volume of patients, the move will allow Hopkins to improve its market position in the Washington-Baltimore region.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, recently announced its management team was flying to China to close its merger with Zhuhai Energy Science and Technology. Biomagnetics Diagnostics is pleased today to announce the signing of the formal merger agreement. All necessary governmental approvals are expected to be completed mid-week.
› Verified 1 days ago